MedPath

Administration study of stimulants to healthy Japanese adult females

Not Applicable
Conditions
ot applicable
Registration Number
JPRN-jRCT1080222264
Lead Sponsor
Mitsubishi chemical Medience Corporation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
Female
Target Recruitment
18
Inclusion Criteria

Weight: more than 40 kg, BMI :more than 17.6 and below 26.4

Exclusion Criteria

-Hypersensitivity to drugs,
-A history of alcoholism or drug addiction,
-Ethical or OTC pharmaceuticals administered within two weeks before scheduled administration of the study drug,
-Supplement, grapefruit or its products, or foods containing Hypericum perforatum
consumed within one week before scheduled administration of the study drug, and
- Not less than 200 mL of blood is collected within 30 days or not less than 400 mL of blood is collected within 90 days before scheduled administration of the study drug.
-A history of Graves' disease, hypertension, cardiac disease, diabetes, glaucoma, prostatomegaly, arteriosclerosis, liver disease, epilepsy, a psychiatric disorder, schizophrenia, and spasm that are not based on a cause. A person who is pregnant or has a chance of becoming pregnant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath